United Therapeutics   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Silver Spring MD United States (1996)

Organization Overview

First Clinical Trial
1998
NCT00004497
First Marketed Drug
2002
treprostinil (remodulin)
First NDA Approval
2002
treprostinil (remodulin)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

EV Clinical Trials | UNITED THERAP | United Therapeutics